Tarsus Pharmaceuticals, Inc. (TARS) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -24.65M | 19.33M | 18.26M | -29.39M | -20.65M | -22.18M | -8.65M | -14.4M | -37.79M | -39.34M | -32.36M | -23.83M | -21.97M | -10.87M | -18.61M | -4.26M | -15.29M | -12.12M | 7.11M | 20.55M |
| Operating CF Margin % | -15.21% | 12.74% | 15.38% | -28.63% | -26.36% | -33.4% | -17.98% | -35.29% | -136.85% | -300.82% | -1729.66% | - | -878.8% | -108.74% | - | -27.88% | -2835.99% | -3586.09% | 573.55% | 93.34% |
| Operating CF Growth % | -19.37% | 187.14% | 311.01% | -104.02% | 45.35% | 43.61% | 73.26% | 39.55% | -72% | -261.73% | -73.89% | -459.43% | -43.73% | 10.29% | -361.68% | -120.72% | -29.61% | -21.05% | 208.22% | 903.72% |
| Net Income | -6.97M | -8.37M | -12.59M | -20.34M | -25.12M | -23.11M | -23.42M | -33.29M | -35.73M | -41.9M | -39.15M | -31.42M | -23.42M | -13.6M | -22.51M | -5.74M | -20.24M | -14.85M | -15.7M | 6.34M |
| Depreciation & Amortization | 437K | 443K | 400K | 453K | 460K | 432K | 284K | 239K | 270K | 347K | 244K | 182K | 104K | 98K | 94K | 92K | 41K | 40K | 83K | 125K |
| Stock-Based Compensation | 0 | 14.31M | 12.24M | 8.23M | 6.93M | 7.4M | 7.42M | 7.48M | 5.52M | 5.48M | 5.25M | 5.19M | 3.91M | 3.67M | 3.58M | 3.53M | 2.67M | 2.18M | 2.12M | 2.79M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 350K | 903K |
| Other Non-Cash Items | 11.35M | -629K | -1.13M | -1.38M | -1.01M | -1.18M | 8.73M | 914K | 742K | -455K | -113K | -891K | -1.15M | -1.13M | 179K | 571K | 606K | 474K | 91K | 44K |
| Working Capital Changes | -29.48M | 13.57M | 19.33M | -16.36M | -1.91M | -5.73M | -1.66M | 10.25M | -8.59M | -2.81M | 1.41M | 3.12M | -1.41M | 85K | 44K | -2.71M | 1.63M | 37K | 20.17M | 10.34M |
| Change in Receivables | -30.1M | -12.77M | -14.1M | 3.91M | -16.09M | -17.75M | 588K | 521K | -13.65M | -11.34M | -6.12M | 2.67M | 665K | 429K | -3.39M | -285K | -17K | 46K | 0 | 5M |
| Change in Inventory | -196K | -536K | 37K | -1.17M | -84K | 227K | -652K | -692K | -929K | -3.09M | -15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -184.67M |
| Change in Payables | 7.71M | -30.54M | 23.84M | 2.29M | 11.31M | 15.05M | 5.87M | 7.09M | 12.34M | 8.06M | 5.81M | 409K | -1.05M | -366K | 1.32M | -2.1M | 1.97M | 357K | -1.1M | -441K |
| Cash from Investing | -58.56M | 49.27M | -4.74M | -51.7M | -34.94M | -59.57M | 3.13M | -40.52M | -102.22M | 17.85M | 47.37M | 64.09M | 11.29M | -87.22M | -57.13M | -122K | -161K | -274K | -121K | -16K |
| Capital Expenditures | -5.82M | -6.36M | -1.91M | -1M | -590K | -72K | -282K | -1.04M | -174K | 0 | -375K | -787K | -340K | -127K | -96K | -122K | -161K | -274K | -121K | -16K |
| CapEx % of Revenue | 3.59% | 4.19% | 1.61% | 0.98% | 0.75% | 0.11% | 0.59% | 2.55% | 0.63% | - | 20.04% | - | 13.6% | 1.27% | - | 0.8% | 29.87% | 81.07% | 9.76% | 0.07% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -5M | 3M | 0 | 0 | 0 | -4M | 0 | 0 | 5.32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.2M | 2.31M | 2.56M | 1.95M | 136.56M | 2.93M | 639K | 42.32M | 108.77M | 19.76M | 104.89M | 510K | 5.01M | 264K | -136K | 74.73M | 19.13M | -74K | 75K | 1K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -31.88M | -39K | 71.52M | 0 | 0 | 5M | 0 | 5M | 0 | 0 | -60K | 19.18M | 0 | 0 | 0 |
| Equity Issued (Net) | 1.2M | 2.31M | 2.56M | 1.95M | 136.56M | 2.93M | 678K | 2.68M | 108.77M | 19.76M | 99.89M | 510K | 13K | 264K | -136K | 74.79M | -60K | -74K | 75K | 1K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 31.88M | 0 | -31.88M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -82.01M | 70.92M | 16.08M | -79.14M | 80.97M | -78.83M | -4.88M | -12.61M | -31.24M | -1.73M | 119.9M | 40.78M | -5.66M | -97.83M | -75.87M | 70.35M | 3.68M | -12.47M | 7.07M | 20.54M |
| Free Cash Flow | -30.47M | 12.97M | 16.35M | -30.39M | -21.24M | -27.25M | -8.93M | -15.44M | -37.96M | -39.34M | -36.74M | -24.61M | -22.31M | -11M | -18.71M | -4.38M | -15.45M | -12.39M | 6.99M | 20.54M |
| FCF Margin % | -18.8% | 8.55% | 13.77% | -29.6% | -27.12% | -41.04% | -18.57% | -37.84% | -137.48% | -300.82% | -1963.5% | - | -892.4% | -110.01% | - | -28.68% | -2865.86% | -3667.16% | 563.79% | 93.27% |
| FCF Growth % | -43.45% | 147.6% | 282.98% | -96.78% | 44.05% | 30.71% | 75.68% | 37.26% | -70.16% | -257.56% | -96.38% | -461.81% | -44.43% | 11.25% | -367.59% | -121.33% | -29.06% | -24.41% | 204.23% | 810.06% |
| FCF per Share | -0.71 | 0.30 | 0.38 | -0.72 | -0.54 | -0.71 | -0.23 | -0.41 | -1.08 | -1.23 | -1.20 | -0.92 | -0.83 | -0.43 | -0.70 | -0.18 | -0.75 | -0.60 | 0.34 | 0.93 |
| FCF Conversion (FCF/Net Income) | 3.54x | -2.31x | -1.45x | 1.44x | 0.82x | 0.96x | 0.37x | 0.43x | 1.06x | 0.94x | 0.83x | 0.76x | 0.94x | 0.80x | 0.83x | 0.74x | 0.76x | 0.82x | -0.45x | 3.26x |
| Interest Paid | 0 | 0 | 2.12M | 0 | 2.07M | 2.17M | 0 | 468K | 868K | 846K | 732K | 709K | 593K | 0 | 967K | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |